{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:04:27Z","timestamp":1789563867599,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12752-4","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:15:31Z","timestamp":1789560931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Collateral sensitivity-harnessing microbial vulnerabilities as a solution to antimicrobial resistance"],"prefix":"10.1007","volume":"53","author":[{"given":"Rishav","family":"Jana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Bhowmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"12752_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.24171\/j.phrp.2022.0323","volume":"14","author":"P Bhowmik","year":"2023","unstructured":"Bhowmik P, Modi B, Roy P, Chowdhury A (2023) Strategies to combat Gram-negative bacterial resistance to conventional antibacterial drugs: a review. PHRP 14:333\u2013346. https:\/\/doi.org\/10.24171\/j.phrp.2022.0323","journal-title":"PHRP"},{"key":"12752_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"12752_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nurpra.2014.10.008","volume":"11","author":"CM Oliphant","year":"2015","unstructured":"Oliphant CM, Eroschenko K (2015) Antibiotic Resistance, Part 2: Gram-negative Pathogens. J Nurse Practitioners 11:79\u201386. https:\/\/doi.org\/10.1016\/j.nurpra.2014.10.008","journal-title":"J Nurse Practitioners"},{"key":"12752_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70676","volume":"10","author":"A Santos-Lopez","year":"2021","unstructured":"Santos-Lopez A, Marshall CW, Haas AL et al (2021) The roles of history, chance, and natural selection in the evolution of antibiotic resistance. eLife 10:e70676. https:\/\/doi.org\/10.7554\/eLife.70676","journal-title":"eLife"},{"key":"12752_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37624-4","volume":"14","author":"DY Liu","year":"2023","unstructured":"Liu DY, Phillips L, Wilson DM et al (2023) Collateral sensitivity profiling in drug-resistant Escherichia coli identifies natural products suppressing cephalosporin resistance. Nat Commun 14:1976. https:\/\/doi.org\/10.1038\/s41467-023-37624-4","journal-title":"Nat Commun"},{"key":"12752_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/emph\/eoz008","volume":"2019","author":"R Roemhild","year":"2019","unstructured":"Roemhild R, Schulenburg H (2019) Evolutionary ecology meets the antibiotic crisis: Can we control pathogen adaptation through sequential therapy? Evol Med Public Health 2019:37\u201345. https:\/\/doi.org\/10.1093\/emph\/eoz008","journal-title":"Evol Med Public Health"},{"key":"12752_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1128\/jb.64.4.489-499.1952","volume":"64","author":"W Szybalski","year":"1952","unstructured":"Szybalski W, Bryson V (1952) Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. J Bacteriol 64:489\u2013499. https:\/\/doi.org\/10.1128\/jb.64.4.489-499.1952","journal-title":"J Bacteriol"},{"key":"12752_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009172","volume":"17","author":"R Roemhild","year":"2021","unstructured":"Roemhild R, Andersson DI (2021) Mechanisms and therapeutic potential of collateral sensitivity to antibiotics. PLoS Pathog 17:e1009172. https:\/\/doi.org\/10.1371\/journal.ppat.1009172","journal-title":"PLoS Pathog"},{"key":"12752_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006609","author":"L Imamovic","year":"2013","unstructured":"Imamovic L, Sommer MOA (2013) Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3006609","journal-title":"Sci Transl Med"},{"key":"12752_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5352","volume":"5","author":"V L\u00e1z\u00e1r","year":"2014","unstructured":"L\u00e1z\u00e1r V, Nagy I, Spohn R et al (2014) Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat Commun 5:4352. https:\/\/doi.org\/10.1038\/ncomms5352","journal-title":"Nat Commun"},{"key":"12752_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2013.57","volume":"9","author":"V L\u00e1z\u00e1r","year":"2013","unstructured":"L\u00e1z\u00e1r V, Pal Singh G, Spohn R et al (2013) Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol 9:700. https:\/\/doi.org\/10.1038\/msb.2013.57","journal-title":"Mol Syst Biol"},{"key":"12752_CR12","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/molbev\/msx158","volume":"34","author":"C Barbosa","year":"2017","unstructured":"Barbosa C, Trebosc V, Kemmer C et al (2017) Alternative evolutionary paths to bacterial antibiotic resistance cause distinct collateral effects. Mol Biol Evol 34:2229\u20132244. https:\/\/doi.org\/10.1093\/molbev\/msx158","journal-title":"Mol Biol Evol"},{"key":"12752_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s42003-025-09303-1","volume":"9","author":"V Chauhan","year":"2025","unstructured":"Chauhan V, Enkvist L, Chukhareva Y et al (2025) Evolutionary trajectories determine feasibility of collateral sensitivity-based antibiotic treatment strategies in critical bacterial pathogens. Commun Biol 9:38. https:\/\/doi.org\/10.1038\/s42003-025-09303-1","journal-title":"Commun Biol"},{"key":"12752_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06143-y","volume":"9","author":"NL Podnecky","year":"2018","unstructured":"Podnecky NL, Fredheim EGA, Kloos J et al (2018) Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli. Nat Commun 9:3673. https:\/\/doi.org\/10.1038\/s41467-018-06143-y","journal-title":"Nat Commun"},{"key":"12752_CR15","doi-asserted-by":"publisher","first-page":"e51481","DOI":"10.7554\/eLife.51481","volume":"8","author":"C Barbosa","year":"2019","unstructured":"Barbosa C, R\u00f6mhild R, Rosenstiel P, Schulenburg H (2019) Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen Pseudomonas aeruginosa. Elife 8:e51481. https:\/\/doi.org\/10.7554\/eLife.51481","journal-title":"Elife"},{"key":"12752_CR16","doi-asserted-by":"publisher","first-page":"14494","DOI":"10.1073\/pnas.1409800111","volume":"111","author":"S Kim","year":"2014","unstructured":"Kim S, Lieberman TD, Kishony R (2014) Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proc Natl Acad Sci U S A 111:14494\u201314499. https:\/\/doi.org\/10.1073\/pnas.1409800111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12752_CR17","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/molbev\/msab006","volume":"38","author":"LJ Jahn","year":"2021","unstructured":"Jahn LJ, Simon D, Jensen M et al (2021) Compatibility of Evolutionary Responses to Constituent Antibiotics Drive Resistance Evolution to Drug Pairs. Mol Biol Evol 38:2057\u20132069. https:\/\/doi.org\/10.1093\/molbev\/msab006","journal-title":"Mol Biol Evol"},{"key":"12752_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009940","volume":"6","author":"C Munck","year":"2014","unstructured":"Munck C, Gumpert HK, Wallin AIN et al (2014) Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci Transl Med 6:262ra156. https:\/\/doi.org\/10.1126\/scitranslmed.3009940","journal-title":"Sci Transl Med"},{"key":"12752_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2004356","volume":"16","author":"C Barbosa","year":"2018","unstructured":"Barbosa C, Beardmore R, Schulenburg H, Jansen G (2018) Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model. PLoS Biol 16:e2004356. https:\/\/doi.org\/10.1371\/journal.pbio.2004356","journal-title":"PLoS Biol"},{"key":"12752_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109370119","volume":"119","author":"S Hernando-Amado","year":"2022","unstructured":"Hernando-Amado S, Laborda P, Valverde JR, Mart\u00ednez JL (2022) Mutational background influences P. aeruginosa ciprofloxacin resistance evolution but preserves collateral sensitivity robustness. Proc Natl Acad Sci U S A 119:e2109370119. https:\/\/doi.org\/10.1073\/pnas.2109370119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12752_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/antibiotics13010094","volume":"13","author":"T Maeda","year":"2024","unstructured":"Maeda T, Furusawa C (2024) Laboratory Evolution of Antimicrobial Resistance in Bacteria to Develop Rational Treatment Strategies. Antibiotics 13:94. https:\/\/doi.org\/10.3390\/antibiotics13010094","journal-title":"Antibiotics"},{"key":"12752_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00983-25","author":"X Wang","year":"2025","unstructured":"Wang X, Nong L, Schaar G et al (2025) Collateral sensitivity and cross-resistance in six species of bacteria exposed to six classes of antibiotics. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.00983-25","journal-title":"Microbiol Spectr"},{"key":"12752_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081335","volume":"12","author":"M Hasan","year":"2023","unstructured":"Hasan M, Wang J, Ahn J (2023) Ciprofloxacin and tetracycline resistance cause collateral sensitivity to aminoglycosides in Salmonella Typhimurium. Antibiotics (Basel, Switzerland) 12:1335. https:\/\/doi.org\/10.3390\/antibiotics12081335","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"12752_CR24","doi-asserted-by":"publisher","first-page":"10222","DOI":"10.1021\/acs.jafc.9b01795","volume":"67","author":"S-C Wu","year":"2019","unstructured":"Wu S-C, Han F, Song M-R et al (2019) Natural flavones from Morus alba against methicillin-resistant Staphylococcus aureus via targeting the proton motive force and membrane permeability. J Agric Food Chem 67:10222\u201310234. https:\/\/doi.org\/10.1021\/acs.jafc.9b01795","journal-title":"J Agric Food Chem"},{"key":"12752_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100961","volume":"68","author":"X Ma","year":"2023","unstructured":"Ma X, Xi W, Yang D et al (2023) Collateral sensitivity between tetracyclines and aminoglycosides constrains resistance evolution in carbapenem-resistant Klebsiella pneumoniae. Drug Resist Updat 68:100961. https:\/\/doi.org\/10.1016\/j.drup.2023.100961","journal-title":"Drug Resist Updat"},{"key":"12752_CR26","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1016\/j.jia.2024.12.005","volume":"25","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Tao M, Wang R et al (2026) Collateral sensitivity to gamithromycin in ciprofloxacin-resistant Streptococcus suis is driven by increasing intracellular antibiotic accumulation. J Integr Agric 25:2959\u20132969. https:\/\/doi.org\/10.1016\/j.jia.2024.12.005","journal-title":"J Integr Agric"},{"key":"12752_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41467-019-08529-y","volume":"10","author":"CEH Rosenkilde","year":"2019","unstructured":"Rosenkilde CEH, Munck C, Porse A et al (2019) Collateral sensitivity constrains resistance evolution of the CTX-M-15 \u03b2-lactamase. Nat Commun 10:618. https:\/\/doi.org\/10.1038\/s41467-019-08529-y","journal-title":"Nat Commun"},{"key":"12752_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2026.169893","volume":"438","author":"D Salamonsen","year":"2026","unstructured":"Salamonsen D, Buda K, Wang D et al (2026) Mechanistic origins and evolutionary erosion of collateral sensitivity in a \u03b2-lactamase. J Mol Biol 438:169893. https:\/\/doi.org\/10.1016\/j.jmb.2026.169893","journal-title":"J Mol Biol"},{"key":"12752_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115987","volume":"44","author":"F Yu","year":"2025","unstructured":"Yu F, Zhu S, Lv Q et al (2025) Lon dysfunction-mediated collateral sensitivity drives effective antibiotic combination therapies against tigecycline-resistant pathogens. Cell Rep 44:115987. https:\/\/doi.org\/10.1016\/j.celrep.2025.115987","journal-title":"Cell Rep"},{"key":"12752_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evac105","volume":"14","author":"Y Cohen","year":"2022","unstructured":"Cohen Y, Hershberg R (2022) Rapid adaptation often occurs through mutations to the most highly conserved positions of the RNA polymerase core enzyme. Genome Biol Evol 14:evac105. https:\/\/doi.org\/10.1093\/gbe\/evac105","journal-title":"Genome Biol Evol"},{"key":"12752_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008672","volume":"16","author":"VV Panchal","year":"2020","unstructured":"Panchal VV, Griffiths C, Mosaei H et al (2020) Evolving MRSA: high-level \u03b2-lactam resistance in Staphylococcus aureus is associated with RNA polymerase alterations and fine tuning of gene expression. PLoS Pathog 16:e1008672. https:\/\/doi.org\/10.1371\/journal.ppat.1008672","journal-title":"PLoS Pathog"},{"key":"12752_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03168-22","volume":"14","author":"Y Patel","year":"2023","unstructured":"Patel Y, Soni V, Rhee KY, Helmann JD (2023) Mutations in rpoB that confer rifampicin resistance can alter levels of peptidoglycan precursors and affect \u03b2-lactam susceptibility. mBio 14:e03168-22. https:\/\/doi.org\/10.1128\/mbio.03168-22","journal-title":"mBio"},{"key":"12752_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2356692","volume":"15","author":"C-Z Wang","year":"2024","unstructured":"Wang C-Z, Zhang Y-J, Chu Y-F et al (2024) Tobramycin-resistant small colony variant mutant of Salmonella enterica serovar Typhimurium shows collateral sensitivity to nitrofurantoin. Virulence 15:2356692. https:\/\/doi.org\/10.1080\/21505594.2024.2356692","journal-title":"Virulence"},{"key":"12752_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2026.105893","volume":"138","author":"Q Jiang","year":"2026","unstructured":"Jiang Q, Li Q, Wu C et al (2026) Exploiting collateral sensitivity to combat antimicrobial resistance: mechanisms and opportunities. Infect Genet Evol 138:105893. https:\/\/doi.org\/10.1016\/j.meegid.2026.105893","journal-title":"Infect Genet Evol"},{"key":"12752_CR35","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/molbev\/msu191","volume":"31","author":"T Oz","year":"2014","unstructured":"Oz T, Guvenek A, Yildiz S et al (2014) Strength of Selection Pressure Is an Important Parameter Contributing to the Complexity of Antibiotic Resistance Evolution. Mol Biol Evol 31:2387\u20132401. https:\/\/doi.org\/10.1093\/molbev\/msu191","journal-title":"Mol Biol Evol"},{"key":"12752_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19713-w","volume":"11","author":"T Maeda","year":"2020","unstructured":"Maeda T, Iwasawa J, Kotani H et al (2020) High-throughput laboratory evolution reveals evolutionary constraints in Escherichia coli. Nat Commun 11:5970. https:\/\/doi.org\/10.1038\/s41467-020-19713-w","journal-title":"Nat Commun"},{"key":"12752_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94645-z","volume":"11","author":"T Maeda","year":"2021","unstructured":"Maeda T, Kawada M, Sakata N et al (2021) Laboratory evolution of Mycobacterium on agar plates for analysis of resistance acquisition and drug sensitivity profiles. Sci Rep 11:15136. https:\/\/doi.org\/10.1038\/s41598-021-94645-z","journal-title":"Sci Rep"},{"key":"12752_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nprot.2013.021","volume":"8","author":"E Toprak","year":"2013","unstructured":"Toprak E, Veres A, Yildiz S et al (2013) Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition. Nat Protoc 8:555\u2013567. https:\/\/doi.org\/10.1038\/nprot.2013.021","journal-title":"Nat Protoc"},{"key":"12752_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ng.1034","volume":"44","author":"E Toprak","year":"2012","unstructured":"Toprak E, Veres A, Michel J-B et al (2012) Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 44:101\u2013105. https:\/\/doi.org\/10.1038\/ng.1034","journal-title":"Nat Genet"},{"key":"12752_CR40","doi-asserted-by":"publisher","unstructured":"Liu PC, Lee YT, Wang CY, Yang Y-T (2016) Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection. J Vis Exp 54426. https:\/\/doi.org\/10.3791\/54426","DOI":"10.3791\/54426"},{"key":"12752_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature13469","volume":"513","author":"O Fridman","year":"2014","unstructured":"Fridman O, Goldberg A, Ronin I et al (2014) Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 513:418\u2013421. https:\/\/doi.org\/10.1038\/nature13469","journal-title":"Nature"},{"key":"12752_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.20","volume":"1","author":"B Van Den Bergh","year":"2016","unstructured":"Van Den Bergh B, Michiels JE, Wenseleers T et al (2016) Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat Microbiol 1:16020. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.20","journal-title":"Nat Microbiol"},{"key":"12752_CR43","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1126\/science.aag0822","volume":"353","author":"M Baym","year":"2016","unstructured":"Baym M, Lieberman TD, Kelsic ED et al (2016) Spatiotemporal microbial evolution on antibiotic landscapes. Science 353:1147\u20131151. https:\/\/doi.org\/10.1126\/science.aag0822","journal-title":"Science"},{"key":"12752_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002970","volume":"23","author":"J Maltas","year":"2025","unstructured":"Maltas J, Huynh A, Wood KB (2025) Dynamic collateral sensitivity profiles highlight opportunities and challenges for optimizing antibiotic treatments. PLoS Biol 23:e3002970. https:\/\/doi.org\/10.1371\/journal.pbio.3002970","journal-title":"PLoS Biol"},{"key":"12752_CR45","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1038\/s41467-023-37357-4","volume":"14","author":"S Hernando-Amado","year":"2023","unstructured":"Hernando-Amado S, Laborda P, Mart\u00ednez JL (2023) Tackling antibiotic resistance by inducing transient and robust collateral sensitivity. Nat Commun 14:1723. https:\/\/doi.org\/10.1038\/s41467-023-37357-4","journal-title":"Nat Commun"},{"key":"12752_CR46","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/molbev\/msv006","volume":"32","author":"M Rodriguez de Evgrafov","year":"2015","unstructured":"Rodriguez de Evgrafov M, Gumpert H, Munck C et al (2015) Collateral resistance and sensitivity modulate evolution of high-level resistance to drug combination treatment in Staphylococcus aureus. Mol Biol Evol 32:1175\u20131185. https:\/\/doi.org\/10.1093\/molbev\/msv006","journal-title":"Mol Biol Evol"},{"key":"12752_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000515","volume":"17","author":"J Maltas","year":"2019","unstructured":"Maltas J, Wood KB (2019) Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance. PLoS Biol 17:e3000515. https:\/\/doi.org\/10.1371\/journal.pbio.3000515","journal-title":"PLoS Biol"},{"key":"12752_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00685","volume":"9","author":"C L\u00f3pez-Causap\u00e9","year":"2018","unstructured":"L\u00f3pez-Causap\u00e9 C, Cabot G, Del Barrio-Tofi\u00f1o E, Oliver A (2018) The versatile mutational resistome of Pseudomonas aeruginosa. Front Microbiol 9:685. https:\/\/doi.org\/10.3389\/fmicb.2018.00685","journal-title":"Front Microbiol"},{"key":"12752_CR49","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1128\/JCM.41.5.2266-2267.2003","volume":"41","author":"D Armstrong","year":"2003","unstructured":"Armstrong D, Bell S, Robinson M et al (2003) Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 41:2266\u20132267. https:\/\/doi.org\/10.1128\/JCM.41.5.2266-2267.2003","journal-title":"J Clin Microbiol"},{"key":"12752_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tim.2025.11.002","volume":"34","author":"K Yang","year":"2026","unstructured":"Yang K, Rasouly A, Nudler E (2026) Collateral sensitivity and genetic vulnerability of antibiotic resistance. Trends Microbiol 34:419\u2013430. https:\/\/doi.org\/10.1016\/j.tim.2025.11.002","journal-title":"Trends Microbiol"},{"key":"12752_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41586-024-07206-5","volume":"628","author":"KA Eckartt","year":"2024","unstructured":"Eckartt KA, Delbeau M, Munsamy-Govender V et al (2024) Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis. Nature 628:186\u2013194. https:\/\/doi.org\/10.1038\/s41586-024-07206-5","journal-title":"Nature"},{"key":"12752_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00770-18","volume":"9","author":"M Knopp","year":"2018","unstructured":"Knopp M, Andersson DI (2018) Predictable phenotypes of antibiotic resistance mutations. mBio 9:e00770-18. https:\/\/doi.org\/10.1128\/mBio.00770-18","journal-title":"mBio"},{"key":"12752_CR53","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/molbev\/msz109","volume":"36","author":"G Apjok","year":"2019","unstructured":"Apjok G, Boross G, Nyerges \u00c1 et al (2019) Limited Evolutionary Conservation of the Phenotypic Effects of Antibiotic Resistance Mutations. Mol Biol Evol 36:1601\u20131611. https:\/\/doi.org\/10.1093\/molbev\/msz109","journal-title":"Mol Biol Evol"},{"key":"12752_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1741-7007-11-14","volume":"11","author":"MF Schenk","year":"2013","unstructured":"Schenk MF, de Visser JAGM (2013) Predicting the evolution of antibiotic resistance. BMC Biol 11:14. https:\/\/doi.org\/10.1186\/1741-7007-11-14","journal-title":"BMC Biol"},{"issue":"1830","key":"12752_CR55","doi-asserted-by":"publisher","first-page":"20160151","DOI":"10.1098\/rspb.2016.0151","volume":"283","author":"T Vogwill","year":"2016","unstructured":"Vogwill T, Kojadinovic M, MacLean RC (2016) Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas. Proc Biol Sci 283:20160151. https:\/\/doi.org\/10.1098\/rspb.2016.0151","journal-title":"Proc Biol Sci"},{"key":"12752_CR56","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1093\/molbev\/msz144","volume":"36","author":"S Hernando-Amado","year":"2019","unstructured":"Hernando-Amado S, Sanz-Garc\u00eda F, Mart\u00ednez JL (2019) Antibiotic resistance evolution is contingent on the quorum-sensing response in Pseudomonas aeruginosa. Mol Biol Evol 36:2238\u20132251. https:\/\/doi.org\/10.1093\/molbev\/msz144","journal-title":"Mol Biol Evol"},{"key":"12752_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41564-024-01857-w","volume":"10","author":"N Sakenova","year":"2024","unstructured":"Sakenova N, Cacace E, Orakov A et al (2024) Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics. Nat Microbiol 10:202\u2013216. https:\/\/doi.org\/10.1038\/s41564-024-01857-w","journal-title":"Nat Microbiol"},{"key":"12752_CR58","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73250","volume":"10","author":"SM Ardell","year":"2021","unstructured":"Ardell SM, Kryazhimskiy S (2021) The population genetics of collateral resistance and sensitivity. Elife 10:e73250. https:\/\/doi.org\/10.7554\/eLife.73250","journal-title":"Elife"},{"key":"12752_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14335-7","volume":"7","author":"T Horinouchi","year":"2017","unstructured":"Horinouchi T, Suzuki S, Kotani H et al (2017) Prediction of cross-resistance and collateral sensitivity by gene expression profiles and genomic mutations. Sci Rep 7:14009. https:\/\/doi.org\/10.1038\/s41598-017-14335-7","journal-title":"Sci Rep"},{"key":"12752_CR60","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1038\/s41467-025-58597-6","volume":"16","author":"S Hernando-Amado","year":"2025","unstructured":"Hernando-Amado S, Gomis-Font MA, Valverde JR et al (2025) Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa. Nat Commun 16:3323. https:\/\/doi.org\/10.1038\/s41467-025-58597-6","journal-title":"Nat Commun"},{"key":"12752_CR61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2507962122","volume":"122","author":"KJ Card","year":"2025","unstructured":"Card KJ, Crozier D, Durmaz A et al (2025) Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus. Proc Natl Acad Sci U S A 122:e2507962122. https:\/\/doi.org\/10.1073\/pnas.2507962122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12752_CR62","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac132","volume":"1","author":"CH Chung","year":"2022","unstructured":"Chung CH, Chandrasekaran S (2022) A flux-based machine learning model to simulate the impact of pathogen metabolic heterogeneity on drug interactions. PNAS Nexus 1:pgac132. https:\/\/doi.org\/10.1093\/pnasnexus\/pgac132","journal-title":"PNAS Nexus"},{"key":"12752_CR63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303165121","volume":"121","author":"DT Weaver","year":"2024","unstructured":"Weaver DT, King ES, Maltas J, Scott JG (2024) Reinforcement learning informs optimal treatment strategies to limit antibiotic resistance. Proc Natl Acad Sci USA 121:e2303165121. https:\/\/doi.org\/10.1073\/pnas.2303165121","journal-title":"Proc Natl Acad Sci USA"},{"key":"12752_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41746-026-02558-w","volume":"9","author":"M Prunella","year":"2026","unstructured":"Prunella M, Romano C, Borri A et al (2026) Evolutionary digital twin framework for optimal aminoglycoside dosing in neonates with suspected sepsis. npj Digit Med 9:367. https:\/\/doi.org\/10.1038\/s41746-026-02558-w","journal-title":"npj Digit Med"},{"key":"12752_CR65","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1128\/AAC.02892-14","volume":"58","author":"N H\u00e4ndel","year":"2014","unstructured":"H\u00e4ndel N, Schuurmans JM, Feng Y et al (2014) Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistance. Antimicrob Agents Chemother 58:4371\u20134379. https:\/\/doi.org\/10.1128\/AAC.02892-14","journal-title":"Antimicrob Agents Chemother"},{"key":"12752_CR66","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.2147\/DDDT.S164316","volume":"12","author":"KI Udekwu","year":"2018","unstructured":"Udekwu KI, Weiss H (2018) Pharmacodynamic considerations of collateral sensitivity in design of antibiotic treatment regimen. Drug Des Devel Ther 12:2249\u20132257. https:\/\/doi.org\/10.2147\/DDDT.S164316","journal-title":"Drug Des Devel Ther"},{"key":"12752_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107564","volume":"66","author":"FR Chowdhury","year":"2025","unstructured":"Chowdhury FR, Banari V, Lesnic V et al (2025) Large scale laboratory evolution uncovers clinically relevant collateral antibiotic sensitivity. Int J Antimicrob Agents 66:107564. https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107564","journal-title":"Int J Antimicrob Agents"},{"key":"12752_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25927-3","volume":"12","author":"LBS Aulin","year":"2021","unstructured":"Aulin LBS, Liakopoulos A, Van Der Graaf PH et al (2021) Design principles of collateral sensitivity-based dosing strategies. Nat Commun 12:5691. https:\/\/doi.org\/10.1038\/s41467-021-25927-3","journal-title":"Nat Commun"},{"key":"12752_CR69","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1086\/511642","volume":"44","author":"K Drlica","year":"2007","unstructured":"Drlica K, Zhao X (2007) Mutant Selection Window Hypothesis Updated. Clin Infect Dis 44:681\u2013688. https:\/\/doi.org\/10.1086\/511642","journal-title":"Clin Infect Dis"},{"key":"12752_CR70","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/antibiotics14010092","volume":"14","author":"T Onita","year":"2025","unstructured":"Onita T, Ishihara N, Yano T (2025) PK\/PD-Guided Strategies for Appropriate Antibiotic Use in the Era of Antimicrobial Resistance. Antibiotics 14:92. https:\/\/doi.org\/10.3390\/antibiotics14010092","journal-title":"Antibiotics"},{"key":"12752_CR71","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.01055-21","volume":"6","author":"RC Allen","year":"2021","unstructured":"Allen RC, Pfrunder-Cardozo KR, Hall AR (2021) Collateral sensitivity interactions between antibiotics depend on local abiotic conditions. mSystems 6:e01055-21. https:\/\/doi.org\/10.1128\/mSystems.01055-21","journal-title":"mSystems"},{"key":"12752_CR72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","volume":"172","author":"L Imamovic","year":"2018","unstructured":"Imamovic L, Ellabaan MMH, Dantas Machado AM et al (2018) Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections. Cell 172:121-134.e14. https:\/\/doi.org\/10.1016\/j.cell.2017.12.012","journal-title":"Cell"},{"key":"12752_CR73","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1093\/nar\/gkm600","volume":"35","author":"V Svetlov","year":"2007","unstructured":"Svetlov V, Belogurov GA, Shabrova E et al (2007) Allosteric control of the RNA polymerase by the elongation factor RfaH. Nucleic Acids Res 35:5694\u20135705. https:\/\/doi.org\/10.1093\/nar\/gkm600","journal-title":"Nucleic Acids Res"},{"key":"12752_CR74","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41564-021-00973-1","volume":"6","author":"A Rasouly","year":"2021","unstructured":"Rasouly A, Shamovsky Y, Epshtein V et al (2021) Analysing the fitness cost of antibiotic resistance to identify targets for combination antimicrobials. Nat Microbiol 6:1410\u20131423. https:\/\/doi.org\/10.1038\/s41564-021-00973-1","journal-title":"Nat Microbiol"},{"key":"12752_CR75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jac\/dkh482","volume":"55","author":"EM Brown","year":"2005","unstructured":"Brown EM, Nathwani D (2005) Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 55:6\u20139. https:\/\/doi.org\/10.1093\/jac\/dkh482","journal-title":"J Antimicrob Chemother"},{"key":"12752_CR76","doi-asserted-by":"publisher","first-page":"13285","DOI":"10.1073\/pnas.0402298101","volume":"101","author":"CT Bergstrom","year":"2004","unstructured":"Bergstrom CT, Lo M, Lipsitch M (2004) Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 101:13285\u201313290. https:\/\/doi.org\/10.1073\/pnas.0402298101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12752_CR77","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69032","volume":"10","author":"AF Feder","year":"2021","unstructured":"Feder AF, Harper KN, Brumme CJ, Pennings PS (2021) Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity. Elife 10:e69032. https:\/\/doi.org\/10.7554\/eLife.69032","journal-title":"Elife"},{"key":"12752_CR78","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.120.238102","volume":"120","author":"MG De Jong","year":"2018","unstructured":"De Jong MG, Wood KB (2018) Tuning spatial profiles of selection pressure to modulate the evolution of drug resistance. Phys Rev Lett 120:238102. https:\/\/doi.org\/10.1103\/PhysRevLett.120.238102","journal-title":"Phys Rev Lett"},{"key":"12752_CR79","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","volume":"69","author":"RA Gatenby","year":"2009","unstructured":"Gatenby RA, Silva AS, Gillies RJ, Frieden BR (2009) Adaptive therapy. Cancer Res 69:4894\u20134903. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3658","journal-title":"Cancer Res"},{"key":"12752_CR80","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/0008-5472.CAN-19-2669","volume":"80","author":"J West","year":"2020","unstructured":"West J, You L, Zhang J et al (2020) Towards Multidrug Adaptive Therapy. Cancer Res 80:1578\u20131589. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2669","journal-title":"Cancer Res"},{"key":"12752_CR81","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64851","volume":"10","author":"E Gjini","year":"2021","unstructured":"Gjini E, Wood KB (2021) Price equation captures the role of drug interactions and collateral effects in the evolution of multidrug resistance. Elife 10:e64851. https:\/\/doi.org\/10.7554\/eLife.64851","journal-title":"Elife"},{"key":"12752_CR82","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2016.0332","volume":"13","author":"E Tekin","year":"2016","unstructured":"Tekin E, Beppler C, White C et al (2016) Enhanced identification of synergistic and antagonistic emergent interactions among three or more drugs. J R Soc Interface 13:20160332. https:\/\/doi.org\/10.1098\/rsif.2016.0332","journal-title":"J R Soc Interface"},{"key":"12752_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008278","volume":"16","author":"Z Dean","year":"2020","unstructured":"Dean Z, Maltas J, Wood KB (2020) Antibiotic interactions shape short-term evolution of resistance in E. faecalis. PLoS Pathog 16:e1008278. https:\/\/doi.org\/10.1371\/journal.ppat.1008278","journal-title":"PLoS Pathog"},{"key":"12752_CR84","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1073\/pnas.0800944105","volume":"105","author":"J-B Michel","year":"2008","unstructured":"Michel J-B, Yeh PJ, Chait R et al (2008) Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci U S A 105:14918\u201314923. https:\/\/doi.org\/10.1073\/pnas.0800944105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12752_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000796","volume":"6","author":"JP Torella","year":"2010","unstructured":"Torella JP, Chait R, Kishony R (2010) Optimal drug synergy in antimicrobial treatments. PLoS Comput Biol 6:e1000796. https:\/\/doi.org\/10.1371\/journal.pcbi.1000796","journal-title":"PLoS Comput Biol"},{"key":"12752_CR86","doi-asserted-by":"publisher","first-page":"12254","DOI":"10.1073\/pnas.1201281109","volume":"109","author":"K Wood","year":"2012","unstructured":"Wood K, Nishida S, Sontag ED, Cluzel P (2012) Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc Natl Acad Sci U S A 109:12254\u201312259. https:\/\/doi.org\/10.1073\/pnas.1201281109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12752_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41567-020-0989-3","volume":"17","author":"S Iram","year":"2021","unstructured":"Iram S, Dolson E, Chiel J et al (2021) Controlling the speed and trajectory of evolution with counterdiabatic driving. Nat Phys 17:135\u2013142. https:\/\/doi.org\/10.1038\/s41567-020-0989-3","journal-title":"Nat Phys"},{"key":"12752_CR88","doi-asserted-by":"publisher","first-page":"e04594","DOI":"10.1128\/spectrum.04594-22","volume":"11","author":"Y Yang","year":"2023","unstructured":"Yang Y, Liu X, Zhou D et al (2023) Alteration of adeS Contributes to Tigecycline Resistance and Collateral Sensitivity to Sulbactam in Acinetobacter baumannii. Microbiol Spectr 11:e04594\u2013e04522. https:\/\/doi.org\/10.1128\/spectrum.04594-22","journal-title":"Microbiol Spectr"},{"key":"12752_CR89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1611594113","author":"JM Boll","year":"2016","unstructured":"Boll JM, Crofts AA, Peters K et al (2016) A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.1611594113","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"12752_CR90","doi-asserted-by":"publisher","first-page":"e0227622","DOI":"10.1128\/spectrum.02276-22","volume":"11","author":"S Hernando-Amado","year":"2023","unstructured":"Hernando-Amado S, L\u00f3pez-Causap\u00e9 C, Laborda P et al (2023) Rapid phenotypic convergence towards collateral sensitivity in clinical isolates of Pseudomonas aeruginosa presenting different genomic backgrounds. Microbiol Spectr 11:e0227622. https:\/\/doi.org\/10.1128\/spectrum.02276-22","journal-title":"Microbiol Spectr"},{"key":"12752_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212292","volume":"25","author":"J Wu","year":"2024","unstructured":"Wu J, Wu S, Liu J et al (2024) Collateral sensitivity to \u03b2-lactam antibiotics in evolved apramycin-resistant MRSA. IJMS 25:12292. https:\/\/doi.org\/10.3390\/ijms252212292","journal-title":"IJMS"},{"key":"12752_CR92","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nchembio.1911","volume":"11","author":"PR Gonzales","year":"2015","unstructured":"Gonzales PR, Pesesky MW, Bouley R et al (2015) Synergistic, collaterally sensitive \u03b2-lactam combinations suppress resistance in MRSA. Nat Chem Biol 11:855\u2013861. https:\/\/doi.org\/10.1038\/nchembio.1911","journal-title":"Nat Chem Biol"},{"key":"12752_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101274","volume":"7","author":"ST Tandar","year":"2026","unstructured":"Tandar ST, Zwep LB, Woudt SHS et al (2026) Clinical prevalence of collateral sensitivity: a systematic exploration of multicentre antimicrobial surveillance data. Lancet Microbe 7:101274. https:\/\/doi.org\/10.1016\/j.lanmic.2025.101274","journal-title":"Lancet Microbe"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12752-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:15:32Z","timestamp":1789560932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12752-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12752"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12752-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1586"}}